Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test



Status:Completed
Conditions:Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:Any
Updated:4/19/2017
Start Date:April 2016
End Date:April 7, 2017

Use our guide to learn which trials are right for you!

The purpose of this study is to evaluate the performance of the Sentosa SA HSV1/2
Qualitative PCR Test. Precision of results and concordance of results with a reference assay
will be evaluated.

This study will utilize residual samples from male and female patients with signs and
symptoms of oral or genital HSV infections. Genital samples will include internal and
external genital lesions such as those collected from lesions of the anus, buttocks, vagina,
labia, or penis. Oral samples will include those collected from lip, gum, and mouth lesions.
For concordance testing, the sample size is based on historical study design and estimates
of the expected prevalence of HSV1 and/or HSV2 in the population enrolled.

Inclusion Criteria:

- Sample was taken from a lesion from an internal or external oral or genital site.

- Sample was submitted to a clinical laboratory for the purpose of testing for the
presence of HSV1 or HSV2.

- The following information about the patient from which the sample was taken is
available: presumptive diagnosis or signs and symptoms causing assay requisition;
site of lesion; age at time of sample collection or date of birth, and sex.

- Sample was collected in universal viral transport media, using a plastic shaft swab
made of either polyester, cotton, rayon or Dacron.

- There is sufficient residual sample to perform both test and reference assays.

Exclusion Criteria:

- Sample leaked during shipment or storage prior to assay.

- Sample has undergone more than 1 freeze-thaw cycle before testing;

- Sample eluent is not clear after centrifugation (refer to section 6.3.1).

- Sample ID is missing or ambiguous.

- Sample is collected using alginate calcium swab.

- Sample handling and storage requirement in section 5.4 not followed
We found this trial at
9
sites
9500 Euclid Avenue
Cleveland, Ohio 44106
216.444.2200
Principal Investigator: Gary Procop, MD
Phone: 216-445-7819
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
4200 Fifth Ave
Pittsburgh, Pennsylvania 15260
(412) 624-4141
Principal Investigator: Nahed Ismail, MD, PhD
Phone: 412-648-8436
University of Pittsburgh The University of Pittsburgh is a state-related research university, founded as the...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
1 Tampa General Cir
Tampa, Florida 33606
(813) 844-7000
Principal Investigator: Raymond Widen, PhD
Phone: 813-844-4261
Tampa General Hospital In a diverse city known for its rich culture and beautiful beaches,...
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Danville, Pennsylvania 17822
Principal Investigator: Donna Wolk, PhD
Phone: 570-214-9367
?
mi
from
Danville, PA
Click here to add this to my saved trials
481 Corporate Drive
Elmwood Park, New Jersey 07407
?
mi
from
Elmwood Park, NJ
Click here to add this to my saved trials
Horsham, Pennsylvania 19044
Principal Investigator: Madhubala Parikh, MD
Phone: 215-442-7677
?
mi
from
Horsham, PA
Click here to add this to my saved trials
2501 Texas 121 Business
Lewisville, Texas 75067
?
mi
from
Lewisville, TX
Click here to add this to my saved trials
Royal Oak, Michigan 48073
?
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Springfield, Massachusetts 01199
?
mi
from
Springfield, MA
Click here to add this to my saved trials